TD Cowen Downgrades Aadi Bioscience Inc (AADI) to Hold

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to TD Cowen Downgrades Aadi Bioscience Inc (AADI) to Hold

Aadi Bioscience Provides PRECISION1 Trial and Corporate Updates

August 20, 2024 5:00 PM EDT

PRECISION1 tumor-agnostic trial unlikely to meet regulatory threshold to support an accelerated approval and will be halted

Aadi will focus on FYARRO® commercial business for its approved indication, PEComa, and conduct a comprehensive strategic review to maximize shareholder value

To further preserve cash position, Aadi will adjust ongoing Phase 2 trials and reduce R&D headcount by 80%, thereby extending cash runway into at least 2H 2026

LOS ANGELES,... More